Work

Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma

Year: 2009

Type: article

Study design: Clinical Trial

Source: Journal of Neuro-Oncology

DOI: 10.1007/s11060-009-9950-0

Authors: David A. Reardon, Annick Desjardins, James J. Vredenburgh, Sridharan Gururangan, Allan H. Friedman, James E. Herndon, Jennifer Marcello, Julie A. Norfleet, Roger E. McLendon, John H. Sampson, Henry S. Friedman

Institution: Duke Medical Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, U.S. Food and Drug Administration, Novartis Pharma, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Center for Research Resources

Awards: G3199277650, G3424063223, G460175554, G4946238614, SRC on Primary Tumors of the CNS, SPORE in Brain Cancer, G845704651

OpenAlex ID: W2054455334

FWCI: 10.85

Cites: 65

Cited by: 232

Related to: 10